CY1108631T1 - Μεθοδοι και συνθεσεις για τη θεραπεια στυτικης δυσλειτουργιας των ανδρων - Google Patents

Μεθοδοι και συνθεσεις για τη θεραπεια στυτικης δυσλειτουργιας των ανδρων

Info

Publication number
CY1108631T1
CY1108631T1 CY20081101396T CY081101396T CY1108631T1 CY 1108631 T1 CY1108631 T1 CY 1108631T1 CY 20081101396 T CY20081101396 T CY 20081101396T CY 081101396 T CY081101396 T CY 081101396T CY 1108631 T1 CY1108631 T1 CY 1108631T1
Authority
CY
Cyprus
Prior art keywords
methods
recommendations
men
straight
male
Prior art date
Application number
CY20081101396T
Other languages
English (en)
Inventor
Ramsey Sallis
Quoc Huan Ha
Original Assignee
Modular Properties Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Modular Properties Ltd filed Critical Modular Properties Ltd
Publication of CY1108631T1 publication Critical patent/CY1108631T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Macromonomer-Based Addition Polymer (AREA)

Abstract

Αποκαλύπτονται μέθοδοι και συνθέσεις για τη θεραπεία σεξουαλικής δυσλειτουργίας των ανδρών. Μια μέθοδος θεραπείας της σεξουαλικής δυσλειτουργίας των ανδρών περιλαμβάνει χορήγηση μιας φαρμακευτικής σύνθεσης που είναι αποτελεσματική να προκαλεί τη διατήρηση μιας στύσης σε έναν άνδρα. Η σύνθεση παρασκευάζεται με βάση τη διαγνωστική αξιολόγηση και ένα στάδιο δοκιμής εξατομικευμένου παρασκευάσματος. Επίσης στην εφεύρεση περιλαμβάνεται μια μέθοδος θεραπείας σεξουαλικής δυσλειτουργίας ανδρών σε ένα πληθυσμό υποκειμένων. Η εφεύρεση παρέχει περαιτέρω εξοπλισμούς (κιτ) για τη θεραπεία της στυτικής δυσλειτουργίας των ανδρών.
CY20081101396T 2002-01-25 2008-12-02 Μεθοδοι και συνθεσεις για τη θεραπεια στυτικης δυσλειτουργιας των ανδρων CY1108631T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35163402P 2002-01-25 2002-01-25
EP03707504A EP1474143B1 (en) 2002-01-25 2003-01-24 Methods and compositions for treating male erectile dysfunction

Publications (1)

Publication Number Publication Date
CY1108631T1 true CY1108631T1 (el) 2014-04-09

Family

ID=27663012

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101396T CY1108631T1 (el) 2002-01-25 2008-12-02 Μεθοδοι και συνθεσεις για τη θεραπεια στυτικης δυσλειτουργιας των ανδρων

Country Status (9)

Country Link
US (1) US7405222B2 (el)
EP (1) EP1474143B1 (el)
AT (1) ATE406900T1 (el)
AU (1) AU2003209350A1 (el)
CY (1) CY1108631T1 (el)
DE (1) DE60323332D1 (el)
DK (1) DK1474143T3 (el)
PT (1) PT1474143E (el)
WO (1) WO2003063776A2 (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090035221A1 (en) * 2002-01-25 2009-02-05 Ramsey Sallis Methods and Compositions for Treatment of Erectile Dysfunction
US20090257956A1 (en) * 2002-01-25 2009-10-15 Ramsey Sallis Treatment Method for Treatment of Erectile Dysfunction and Premature Ejaculation
US8287474B1 (en) 2002-08-22 2012-10-16 Koenig J Frank Method and apparatus for noninvasively increasing whole body blood flow and noninvasive physical exercise of limbs from the outside and from within the limb to treat diseases throughout the body
JP4667369B2 (ja) 2003-03-21 2011-04-13 ネックスメド ホールディングス インコーポレイテッド 早漏を治療するための組成物および方法
DE102006022554B4 (de) * 2006-05-15 2014-12-04 Roche Diagnostics Gmbh Verfahren und Vorrichtung zum Stimulieren eines Gewebes für die subkutane Verabreichung von Wirkstoffen
US7718595B2 (en) * 2008-06-17 2010-05-18 Colgate Palmolive Company Light duty liquid cleaning compositions and methods of manufacture and use thereof comprising organic acids
US8147848B2 (en) 2009-08-26 2012-04-03 Allergan, Inc. Method for treating premature ejaculation with a botulinum neurotoxin
US9192613B1 (en) 2014-10-14 2015-11-24 Sapere Ip, Llc Treatment method for primary premature ejaculation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127118B1 (en) 1977-03-16 1995-12-19 Alvaro Latorre Method of effecting and enhancing an erection
US5256652A (en) * 1987-11-12 1993-10-26 Pharmedic Co. Topical compositions and methods for treatment of male impotence
FR2649613B1 (fr) * 1989-07-11 1991-09-27 Virag Ronald Medicament vaso-actif
GB9423910D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US6323211B1 (en) 1996-02-02 2001-11-27 Nitromed, Inc. Compositions and methods for treating sexual dysfunctions
US6127363A (en) * 1997-10-28 2000-10-03 Vivus, Inc. Local administration of Type IV phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
GB9823102D0 (en) 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
US6303135B1 (en) 1999-07-08 2001-10-16 Neal R. Cutler Use of quinolines and quinolones to treat male erectile dysfunction
US6323241B1 (en) 2000-01-10 2001-11-27 Nexmed (Holdings) Inc. Prostaglandin compositions and methods of treatment for male erectile dysfunction

Also Published As

Publication number Publication date
WO2003063776A2 (en) 2003-08-07
EP1474143A4 (en) 2005-05-11
WO2003063776A3 (en) 2003-10-23
DE60323332D1 (de) 2008-10-16
AU2003209350A1 (en) 2003-09-02
ATE406900T1 (de) 2008-09-15
EP1474143B1 (en) 2008-09-03
EP1474143A2 (en) 2004-11-10
PT1474143E (pt) 2009-01-02
US20030144318A1 (en) 2003-07-31
US7405222B2 (en) 2008-07-29
DK1474143T3 (da) 2009-01-26

Similar Documents

Publication Publication Date Title
CY1108631T1 (el) Μεθοδοι και συνθεσεις για τη θεραπεια στυτικης δυσλειτουργιας των ανδρων
CY1109783T1 (el) Μεθοδοι και συνθεσεις για την αντιμετωπιση της φλεγμονωδους νοσου του πεπτικου
ECSP055839A (es) COMPOSICIONES Y MÉTODOS PARA TRATAR LA ADMINISTRACIÓN MEJORADA POR VIA MUCOSA DE PÉPTIDOS FIJADORES AL RECEPTOR Y2 y MÉTODOS PARA TRATAR Y PREVENIR LA OBESIDAD
HUP0103346A2 (hu) Készítmény és eljárás péniszerekció diszfunkció kezelésére
DE60335743D1 (de) Verbindungen und verfahren zur erhöhung der neurogenese
MX9602818A (es) Un metodo de tratamiento de infeccion parasitaria usando antagonistas ige.
DE602004031462D1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
EP1308724A3 (en) Buccal dissolution test for pharmaceutically active substrates
DK1496895T3 (da) Anvendelse af cyclopamin til behandling af psoriasis og andre hudlidelser
DE60328128D1 (de) Verfahren zur schmerzbehandlung durch verabreichung eines antagonistischen antikörpers gegen den nervenwachstumfaktor und eines opioid-analgetikums sowie diese enthaltende zusammensetzungen
HUP0001089A2 (hu) Gyógyászati készítmények férfiak erekciós zavarainak kezelésére
HUP0004350A2 (hu) Vegyületek női szexuális diszfunkció kezelésére
DE69822295D1 (de) Verwendung von misoprostol und/oder misoprostolsäure zur behandlung von erektionsstörungen
CY1106227T1 (el) Συνθεση για τη διευκολυνση του ανθρωπινου τοκετου
BRPI0411324A (pt) composições farmacêuticas e métodos de tratamento de resposta mediada por histamina em pacientes
NO20055390L (no) Thorium-227 for anvendelse i radioterapi pa mykvevssykdommer
SE9603725D0 (sv) New teatment
DE60232244D1 (de) Nachweis und behandlung von prostatakrebs
BR0307022A (pt) Método de tratamento de um paciente que precisa de analgesia
DE69630787T2 (de) Mittel und verfahren zur behandlung t-zellen vermittelter krankheiten
EP1930009A3 (en) Methods and compositions for treating male erectile dysfunction
BR9907150A (pt) Métodos e kits para tratar candidìase vulvovaginal com nitrato de miconazol
Werczberger et al. Disseminated Echinococcosis with Repeated Anaphylactic Shock: Treated with Mebendazole
BR0209613A (pt) Composição para tratamento de dor em um mamìfero, e, método para redução ou eliminação de probabilidade de viciamento de um analgésico em um hospedeiro
BR0111900A (pt) Uso de um antagonista do receptor do tipo 1 da angiotensina ii, formulação farmacêutica, e, métodos para o tratamento de uma condição de cefaléia vascular e para o tratamento de enxaqueca